1 470 nm-laser enucleation of the prostate for treatment of benign prostatic hyperplasia (a report of 28 cases)
Cai Xingjian
Zhang Muchun
Zhang Zhuo
Zhang Yun
Zhang Dehua
Abstract：Objective: To study the short-term clinical efficacy and safety of 1 470 nm-laser enucleation of the prostate for benign prostatic hyperplasia.Methods: The clinical data of 28 cases undergoing enucleation of prostate with domestic 1 470 nm-laser from December 2015 to March 2016 were briefly summarized.Results: The 1 470 nm-laser enucleation of the prostate was successfully performed on 28 cases,with less blood loss and no blood transfusion.The average operation time was (94.0±19.7) min.There was no significant difference in instant concentrations before and after operation (P>0.05).The postoperative bladder washing time was (1.6±0.5) days,indwelling catheter time was (4.1±1.0) days,and the length of hospital stay was (6.0±1.5) days.After a 3-month follow-up,International Prostatic Symptom score (IPSS),quality of life (QOL) score,maximum flow rates (Qmax),and postvoid residual volume (PVR) were significantly improved,and the difference was statistically significant (P<0.01).Transient urinary incontinence recovered within one month after pelvic muscle exercises in 4 cases.There were no patients with urethral stricture or the need for a further surgery.Conclusions: Treatment of benign prostatic hyperplasia with 1 470 nm-laser enucleation of the prostate is a safe and effective surgical method,with few complications and speedy recovery.
Keywords：benign prostatic hyperplasia1 470 nm laserenucleation of the prostate
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 275-277 )